Apart from PD-1/PD-L1 signaling, there is a lack of knowledge regarding other immune checkpoint molecules, including the CD200/CD200R axis, concerning MCC evolution and prognosis [9,10,11]. This evidence concerns the gene CD200R1 and Merkel cell skin cancer.